At iQue® (formerly Intellicyt), our mission is to enable bioscience enterprises to rapidly and cost effectively screen and profile disease- and physiologically-relevant model systems for phenotypic endpoints using cell-based and/or bead-based assays. We do this by providing easy-to-use hardware, software, and reagent systems that are optimized to conserve precious samples, use less reagent, and to minimize time-to-answer to both enhance workflow productivity and to preserve the biology of interest. All major pharmaceutical companies and many biotechnology companies and academic institutions have invested in iQue® Advanced Flow Cytometry Platform solutions, to give their cell-based screening campaigns the edge.